IJGC conversations

IJGC EiC Summer Podcasts: ctDNA in Endometrial Cancer with Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds to discuss ctDNA in Endometrial Cancer .
Dr. Capasso completed her OBGYN residency at Fondazione Policlinico Agostino Gemelli (Rome, Italy), where she worked in the Gynecologic Oncology Unit with a focus on clinical and translational research in endometrial cancer. From May 2022 to May 2023, she was a Visiting Research Fellow at Mayo Clinic (Rochester, MN, USA), leading projects on AI, the microbiome, and ctDNA in endometrial cancer. She is currently a consultant in the Gynecologic Oncology Unit at Gemelli and continues to collaborate with Mayo Clinic as a research collaborator.
Camilla Nero, MD, PhD, is a clinician-scientist in the Division of Gynecologic Oncology at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, where her translational work focuses on gynecological cancers. She has authored key studies on dual CDK12/13 inhibition in patient-derived ovarian cancer organoids and numerous reviews on treatment resistance and novel therapeutic strategies. In 2024, she was awarded the AIRC Next Gen Clinician Scientist Grant to support her independent research in gynecological cancers at Gemelli.
Evelyn A. Reynolds, M.D., is a board-certified Gynecologic Oncologist specializing in surgical care for women with gynecologic cancers. She has hed faculty positions at the University of Kansas and Morehouse School of Medicine. Since returning to Mayo Clinic in 2023, she has also expanded her academic role, focusing her research on the early detection of endometrial cancer, optimizing surgical outcomes and reducing healthcare disparities.

IJGC EiC Summer Podcasts: MIS in Simple Hysterectomy: SHAPE Subanaylsis with Marie Plante

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Marie Plante to discuss minimally invasive surgery in simple hysterectomy from the subanalysis of SHAPE trial.
Dr. Plante has a major interest in minimally invasive surgical (MIS) approaches in the treatment of gynecologic cancers and in fertility-preserving surgery for young women with cervical cancer. She is currently leading two important international trials, the SHAPE trial and the Contessa trial.

Impact of Surgical Timing and Residual Disease in Ovarian Cancer with Martina Angeles and Alejandra Martinez

In this IJGC podcast, Dr. Pedro Ramirez discusses Impact of Surgical Timing and Residual Disease in Ovarian Cancer with Martina Angeles and Alejandra Martinez.
Martina Angeles is a gynecologic oncology specialist at Vall d’Hebron University Hospital in Barcelona. She trained in Obstetrics and Gynecology at Hospital Clínic de Barcelona and completed an ESGO-accredited fellowship in gynecologic oncology (2018–2020). In 2023, she earned her PhD from the Autonomous University of Madrid, focusing on the role of surgery in advanced ovarian cancer. She is an Editorial Board Member of the IJGC and former ENYGO–IJGC Editorial Fellow. Her main research interest is advanced ovarian cancer.
Prof. Alejandra Martinez has been the Deputy Head of the Surgical Oncology Department at Toulouse University Cancer Center (Institut Universitaire du Cancer de Toulouse) since 2016. She has served as the Director of the ESGO fellowship program of the IUCTO since 2017 and as a professor in oncology since 2021.

Impact of RCTs on Clinical Practice with Floriane Jochum

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Floriane Jochum to discuss Impact of RCTs on Clinical Practice. 
Dr. Floriane Jochum is a Gynecologic Oncologist at Strasbourg University Hospital in France. She completed her PhD in cancer research and computational epidemiology at Institut Curie in Paris. Her doctoral work focused on the multiple applications of real-world data in gynecologic oncology, exploring topics ranging from disparities in access to care to the development of emulated clinical trials. 

Lymphadenectomy in Low-Grade Ovarian Cancer with Elizabeth Tubridy and Dimitrios Nasioudis

In this IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez discusses Lymphadenectomy in Low-Grade Ovarian Cancer with Elizabeth Tubridy and Dimitrios Nasioudis. 
Elizabeth Tubridy is a 3rd year Gynecologic Oncology Fellow at the Hospital of the University of Pennsylvania. She received her Bachelor of Science from Georgetown University and obtained her medical degree from Albert Einstein College of Medicine. She completed her Obstetrics and Gynecology residency at New York University Medical Center.  Upon graduation she will be joining the Gynecologic Oncology practice at White Plains Hospital in New York. Her research focuses include the role of tumor infiltrating lymphocytes in ovarian cancer as well as equity and inclusion in Gyn Oncology clinical trials.Dimitrios Nasioudis is an Assistant Professor of Obstetrics and Gynecology at the University of Pennsylvania. He obtained his medical degree from the Aristotle University of Thessaloniki and completed his residency and fellowship training at the Hospital of the University of Pennsylvania. He is also a member of the Society of Gynecologic Oncology, a Fellow of the American College of Obstetricians and Gynecologists, and a member of the European Society of Gynaecological Oncology. His main research focus is the development of novel therapeutics and population-based outcomes research focusing on rare gynecologic cancers.

IJGC conversations 2025 July Editor's Choice

In this episode of the IJGC conversations 2025 July Editor's Choice, Editorial Fellow Helena Obermair and Friederike Stroisch discusses the contents of the 2025 July issue of IJGC. 
 
 

ctDNA in Ovarian Cancer with Henri Azaïs

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Henri Azaïs to discuss ctDNA in Ovarian Cancer. 
Dr. Henri Azaïs is a gynaecological surgeon specialising in the surgical management of gynaecological cancers at the Hôpital Européen Georges Pompidou in Paris - France. His translational research focuses on late-stage ovarian cancer and in particular on the role of circulating tumour DNA in this disease.
 

2025 GTD Guidelines with Christianne Lok and Michael Seckl

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Christianne Lok and Michael Seckl to discuss 2025 GTD Guidelines. 
Christianne Lok is a leading expert in gynecologic oncology, renowned for her work on cancer diagnosis and treatment during pregnancy as part of the International Network on Cancer, Infertility and Pregnancy (INCIP). She plays a pivotal role in research and clinical guidelines for gestational trophoblastic disease, addressing both medical and psychosocial dimensions. Her contributions to ovarian cancer research include biomarker studies—particularly on ctDNA and HE4—as well as molecular profiling and biobanking of rare ovarian cancer subtypes. Lok actively participates in international collaborations such as ESGO, GCIG, ISSTD, ENGOT and EOTTD, shaping global standards in women’s cancer care. Her prolific publication record underscores her influence in advancing multidisciplinary, patient-centered research.
Michael Seckl is a Professor of Molecular Oncology at Imperial College London, where he leads research in lung cancer and trophoblastic disease. He earned his medical degree from UCL, completed oncology training, and obtained a PhD in signal transduction from the University of London. He directs the National Trophoblastic Disease and MOGCT Centre. An international leader in trophoblastic disease, he has held key roles in ISSTD, EOTTD, and EURACAN, and serves on multiple editorial and grant committees. His work is widely funded and recognized, earning him a Fellowship of the Academy of Medical Sciences (FMedSci) in 2017.

Peritoneal Cytology in Endometrial Cancer with Diletta Fumagalli and Gretchen E. Glaser

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Diletta Fumagalli and Gretchen E. Glaser to discuss Peritoneal Cytology in Endometrial Cancer. 
 
Dr. Diletta Fumagalli, M.D., is a research fellow at the Istituto Europeo di Oncologia (IEO), Milan, Italy. She has completed a research fellowship at Mayo clinic. Her research and clinical interests include innovative methods for early detection of endometrial cancer and the evaluation of nutritional risks in patients with ovarian cancer. 
 
Dr. Gretchen E. Glaser, M.D., is a Gynecologic Oncologist in Mayo Clinic. Dr. Glaser focuses her clinical research in endometrial cancer treatment and outcomes as well as quality improvement of surgical care using enhanced recovery after surgery techniques. She also performs qualitative education research and holds several leadership positions. Dr. Glaser works on multiple national committees, including as chair of the Society of Gynecologic Oncology Wellness Committee.

Radiation alone vs Chemoradiation in Intermediate Risk Cervical Cancer with Drs. Agustí and Viveros-Carreño

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Núria Agustí and David Viveros-Carreño to discuss Radiation alone vs Chemoradiation in Intermediate Risk Cervical Cancer. Dr. Agustí specializes in gynecologic oncology at Hospital Clinic of Barcelona. She is currently a PhD researcher at the University of Barcelona and engaged in a postdoctoral fellowship at MD Anderson Cancer Center, USA. She recently completed the IJGC Editorial Fellowship program. Dr. Viveros-Carreño is a Gynecologic Oncologist at Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo (CTIC), and Clínica Universitaria Colombia in Bogotá, Colombia.